首页> 中文期刊> 《中国医学创新 》 >替吉奥治疗老年胃癌患者的临床应用疗效分析

替吉奥治疗老年胃癌患者的临床应用疗效分析

             

摘要

目的:通过用替吉奥来治疗老年胃癌患者,观察治疗结果的疗效以及产生的不良反应情况,对患者的满意度进行调查统计。方法:选取入住本院的老年胃癌患者96例,随机分为治疗组和对照组两组,治疗组采用替吉奥胶囊来治疗,对照组采用奥沙利铂联合亚叶酸钙和氟尿嘧啶方案治疗。结果:治疗组总有效率为87.5%,对照组总有效率为72.9%,差异有统计学意义(P<0.05);两组不良反应情况比较,主要的不良反应体现在肝功能损伤、骨髓抑制、胃肠道反应三个方面,治疗组的患者出现Ⅲ-IV 级毒副作用的有7例(14.5%),而对照组为13例(27.1%),比较差异有统计学意义(P<0.05)。两组治疗满意情况统计显示,治疗组患者的满意度为66.7%,对照组为56.3%,比较差异无统计学意义(P>0.05)。结论:替吉奥用于治疗老年胃癌患者的疗效显著,不良反应少,值得临床推广使用。%Objective:To explore and statistical analysis clinical effects,adverse effects and patient satisfactions in the treatment of elderly patients with gastric cancer by TS-1.Method:96 patients with elderly gastric cancer were randomly divided into two groups.The treatment group were treated with TS-1,the control group were treated with oxaliplatin combined with calcium folinate and fluorouracil.Result:The total effective rate of treatment group and control group were 87.5% and 72.9%,with a statistically significant difference(P<0.05);the adverse reactions in the two groups mainly reflected in hepatic injury,myelosuppression and gastrointestinal infection.Compared to 13 cases(27.1%)in the control group,there were 7 cases(14.5%) appeared Ⅲ -IV grade side effects in the treatment group,which had a significant difference(P<0.05).The satisfaction of treatment group and control group were 66.7% and 56.3% respectively,the treatment satisfaction statistics showed that there were no significant difference(P>0.05).Conclusion:TS-1 has a significant efficacy and few adverse effect for the treatment of elderly patients with gastric cancer,which is worth applying in the clinical.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号